Skip to Content

Heparin flush Pregnancy and Breastfeeding Warnings

Heparin flush is also known as: Hep-Lock, Heparin Lock Flush, Monoject Prefill Advanced, PosiFlush

Heparin flush Pregnancy Warnings

Heparin has been assigned to pregnancy category C by the FDA. Animal studies have not been conducted and there are no controlled data in human pregnancy. It does not cross the placenta due to its large molecular weight (3,000 to 30,000 daltons). Heparin is considered the anticoagulant of choice during pregnancy, although anticoagulation and maternal disease state may pose a risk to both the mother and fetus. Heparin is only recommended for use during pregnancy when benefit outweighs risk.

See references

Heparin flush Breastfeeding Warnings

Heparin is not excreted into human milk due to its large molecular weight (3,000 to 30,000 daltons). Heparin is considered compatible with breast-feeding.

See references

References for pregnancy information

  1. Chan WS, Anand S, Ginsberg JS "Anticoagulation of pregnant women with mechanical heart valves - A systematic review of the literature." Arch Intern Med 160 (2000): 191-6
  2. Nageotte MP, Freeman RK, Garite TJ, Block RA "Anticoagulation in pregnancy." Am J Obstet Gynecol 141 (1981): 472-3
  3. Masamoto H, Toma T, Sakumoto K, Kanazawa K "Clearance of antiphospholipid antibodies in pregnancies treated with heparin - Reply." Obstet Gynecol 98 (2001): 162
  4. Bergqvist A, Bergqvist D, Hallbook T "Deep vein thrombosis during pregnancy." Acta Obstet Gynecol Scand 62 (1983): 443-8
  5. Flessa HC, Kapstrom AB, Glueck HI, Will JJ "Placental transport of heparin." Am J Obstet Gynecol 93 (1965): 570-3
  6. Fausett MB, Vogtlander M, Lee RM, Esplin MS, Branch DW, Rodgers GM, Silver RM "Heparin-induced thrombocytopenia is rare in pregnancy." Am J Obstet Gynecol 185 (2001): 148-52
  7. McIntyre JA, Wagenknecht DR, Faulk WP "Clearance of antiphospholipid antibodies in pregnancies treated with heparin." Obstet Gynecol 98 (2001): 162
  8. Toglia MR, Weg JG "Venous thromboembolism during pregnancy." N Engl J Med 335 (1996): 108-14
  9. Aarskog D, Aksnes L, Markestad T, Ulstein M, Sagen N "Heparin-induced inhibition of 1,25-dihydroxyvitamin D formation." Am J Obstet Gynecol 148 (1984): 1141-2
  10. Ginsburg JS, Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R "Heparin therapy during pregnancy." Arch Intern Med 149 (1989): 2233-6
  11. "Product Information. Heparin Lock Flush (heparin flush)." Hospira Inc, Lake Forest, IL.
  12. Hall JG, Pauli RM, Wilson KM "Maternal and fetal sequelae of anticoagulation during pregnancy." Am J Med 68 (1980): 122-40
  13. Howell R, Fidler J, Letsky E, De Swiet M "The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial." Br J Obstet Gynaecol 90 (1983): 1124-8

References for breastfeeding information

  1. "Product Information. Heparin Lock Flush (heparin flush)." Hospira Inc, Lake Forest, IL.
  2. Ginsberg JS, Hirsh J "Use of antithrombotic agents during pregnancy." Chest 108 Suppl (1995): s305-11

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.